Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$370,904
-$347,466 QoQ
Shares Held
15,403
-39.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,958
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CFO4Life Group, LLC holds $7,374,448 across 8 Drug Manufacturers - General names. PFE ranks #7 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,539 | $2,676,589 | |
| 2 | LLY |
ELI LILLY & Co
|
1,589 | $1,905,894 | |
| 3 | NVS |
Novartis AG
|
4,916 | $770,435 | |
| 4 | AMGN |
Amgen Inc
|
1,340 | $485,240 | |
| 5 | ABBV |
AbbVie Inc.
|
1,745 | $439,111 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,156 | $398,729 | |
| 7 | PFE |
Pfizer Inc
This page
|
15,403 | $370,904 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,549 | $327,546 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $370,904 | 15,403 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $718,370 | 25,583 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $672,200 | 26,996 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $682,940 | 26,803 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $631,233 | 26,041 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $641,963 | 25,334 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $762,074 | 28,725 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $813,532 | 28,111 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $762,399 | 27,248 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $713,258 | 25,703 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $711,631 | 24,718 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $855,653 | 25,796 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $1,036,136 | 28,248 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,164,758 | 28,548 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,473,047 | 28,748 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,201,343 | 27,453 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $1,526,918 | 29,123 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $1,655,449 | 31,977 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,926,978 | 32,633 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,469,178 | 34,159 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,221,831 | 31,201 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $1,211,096 | 33,428 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $1,366,939 | 37,135 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $1,217,301 | 33,169 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,075,177 | 32,880 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $1,096,441 | 33,592 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||